{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:22:50Z","timestamp":1790180570314,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003559","name":"Korea Ministry of National Defense","doi-asserted-by":"publisher","award":["2022MDG016"],"award-info":[{"award-number":["2022MDG016"]}],"id":[{"id":"10.13039\/501100003559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002460","name":"Chung-Ang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vaccine.2024.05.054","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T20:31:48Z","timestamp":1716841908000},"page":"126006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cost-benefit analysis of human adenovirus vaccine development in a Korean military setting"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2995-7506","authenticated-orcid":false,"given":"Jungmin","family":"Eom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonjae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Hwan","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Woo","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9359-6522","authenticated-orcid":false,"given":"Hyesook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-9975","authenticated-orcid":false,"given":"Bomi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.05.054_b0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/313999","article-title":"Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group","volume":"31","author":"Gray","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.054_b0010","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.vaccine.2005.12.062","article-title":"Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999\u20132004","volume":"24","author":"Russell","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.054_b0015","doi-asserted-by":"crossref","unstructured":"Yoo H, Gu SH, JungJ, Song DH, Yoon C, Hong DJ, et al. Febrile respiratory illness associated with human adenovirus type 55 in South Korea military, 2014-2016. Emerg Infect Dis 2017;23:1016\u201320. Doi: 10.3201\/eid2306.161848.","DOI":"10.3201\/eid2306.161848"},{"key":"10.1016\/j.vaccine.2024.05.054_b0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3904\/kjim.2019.092","article-title":"Ongoing outbreak of human adenovirus-associated acute respiratory illness in the Republic of Korea military, 2013 to 2018","volume":"36","author":"Ko","year":"2021","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.vaccine.2024.05.054_b0025","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.3346\/jkms.2024.39.e38","article-title":"Prevalence and burden of human adenovirus-associated acute respiratory illness in the Republic of Korea military, 2013 to 2022","volume":"39","author":"Kim","year":"2024","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2024.05.054_b0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/milmed\/160.6.300","article-title":"Adenovirus vaccines in the U.S. military","volume":"160","author":"Gaydos","year":"1995","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2024.05.054_b0035","first-page":"185","article-title":"Control of adenovirus acute respiratory disease in U.S. Army trainees","volume":"48","author":"Top","year":"1975","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.vaccine.2024.05.054_b0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/oxfordjournals.aje.a121499","article-title":"Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966\u20131971","volume":"97","author":"Dudding","year":"1973","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2024.05.054_b0045","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/cid\/ciu507","article-title":"Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines","volume":"59","author":"Radin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.054_b0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3201\/eid2301.161297","article-title":"Acute respiratory disease in US army trainees 3 years after reintroduction of adenovirus vaccine (1)","volume":"23","author":"Clemmons","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.054_b0055","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/infdis\/128.6.745","article-title":"Adenovirus vaccines in military recruit populations: a cost-benefit analysis","volume":"128","author":"Collis","year":"1973","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.054_b0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0749-3797(97)00064-0","article-title":"Prevention of adenoviral acute respiratory disease in Army recruits: cost-effectiveness of a military vaccination policy","volume":"14","author":"Howell","year":"1998","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2024.05.054_b0065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4269\/ajtmh.2000.62.613","article-title":"Cost-effectiveness analysis of reacquiring and using adenovirus types 4 and 7 vaccines in naval recruits","volume":"62","author":"Hyer","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.05.054_b0070","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3201\/eid2407.171222","article-title":"Molecular epidemiology of human adenovirus-associated febrile respiratory illness in soldiers, South Korea(1)","volume":"24","author":"Heo","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.054_b0075","doi-asserted-by":"crossref","first-page":"e0170592","DOI":"10.1371\/journal.pone.0170592","article-title":"Clinical features and courses of adenovirus pneumonia in healthy young adults during an outbreak among Korean military personnel","volume":"12","author":"Park","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.05.054_b0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3346\/jkms.2017.32.2.287","article-title":"Characteristics of adenovirus pneumonia in Korean military personnel, 2012\u20132016","volume":"32","author":"Yoon","year":"2017","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2024.05.054_b0085","doi-asserted-by":"crossref","first-page":"793","DOI":"10.46234\/ccdcw2021.197","article-title":"Outbreaks of acute respiratory disease associated with human adenovirus infection in closed camps, China, December 2011-March 2014","volume":"3","author":"Du","year":"2021","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.vaccine.2024.05.054_b0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12879-020-05258-2","article-title":"An outbreak of acute respiratory infection at a training base in Beijing, China due to human adenovirus type B55","volume":"20","author":"Lu","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.054_b0095","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JCM.01928-09","article-title":"Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP","volume":"48","author":"Kajon","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2024.05.054_b0100","unstructured":"Ministry of National Defense. 2022 Gug-bang-tong-gye-yeon-bo [2022 National Defense Statistical Yearbook]. Ministry of National Defense of the Republic of Korea, https:\/\/www.mnd.go.kr\/user\/boardList.action?command=view&page=1&boardId=O_46843&boardSeq=I_10527078&titleId=&siteId=mnd&id=mnd_050600000000&column=null&search=null; 2023 [accessed 20 December 2022]."},{"key":"10.1016\/j.vaccine.2024.05.054_b0105","doi-asserted-by":"crossref","unstructured":"Kuschner RA, Russell KL, Abuja M, Bauer KM, Faix DJ, Hait H, et al. Adenovirus Vaccine Efficacy Trial, C. (2013). A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits. Vaccine 2013;31:2963\u201371. Doi: 10.1016\/j.vaccine.2013.04.035.","DOI":"10.1016\/j.vaccine.2013.04.035"},{"key":"10.1016\/j.vaccine.2024.05.054_b0110","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1016\/j.vaccine.2021.07.029","article-title":"Cost-benefit analysis of vaccination against four preventable diseases in older adults: Impact of an aging population","volume":"39","author":"Carrico","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.054_b0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vaccine.2012.10.084","article-title":"Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials","volume":"31","author":"DiazGranados","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.054_b0120","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1056\/NEJMoa2116154","article-title":"Vaccine efficacy in adults in a respiratory syncytial virus challenge study","volume":"386","author":"Schmoele-Thoma","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.054_b0125","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"1997"},{"key":"10.1016\/j.vaccine.2024.05.054_b0130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3346\/jkms.2015.30.4.353","article-title":"Vaccination policy in Korean armed forces: current status and future challenge","volume":"30","author":"Heo","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2024.05.054_b0135","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.3346\/jkms.2022.37.e23","article-title":"Analyses of confirmed COVID-19 cases among Korean military personnel after mass vaccination","volume":"37","author":"Shin","year":"2022","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2024.05.054_b0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7883\/yoken.66.359","article-title":"Outbreak of febrile respiratory illness caused by adenovirus at a South Korean military training facility: clinical and radiological characteristics of adenovirus pneumonia","volume":"66","author":"Hwang","year":"2013","journal-title":"Jpn J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T22:08:54Z","timestamp":1737583734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24006224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":28,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0264410X24006224"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-benefit analysis of human adenovirus vaccine development in a Korean military setting","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126006"}}